Plasma-derived biotherapeutics manufacturer for hematology and immunology
Biotest manufactures plasma proteins and biotherapeutics for blood-clotting disorders, infections, and immune system dysfunction. The company runs a heavily SAP-centric infrastructure (ECC, S/4HANA, HANA, Analytics Cloud, BTP) alongside manufacturing-control systems (Siemens S7, TIA Portal), now migrating to SAP BTP—a shift reflecting enterprise modernization. The project and hiring mix is automation-heavy: commissioning and validating process equipment, designing control systems, and multi-year automation investment planning dominate, with manufacturing roles outnumbering engineering 3:1, suggesting execution-focused operations rather than greenfield development.
Notable leadership hires: Production Lead
Biotest is a public pharmaceutical manufacturer headquartered in Dreieich, Germany, with over 2,800 employees worldwide. The company develops and produces plasma-derived biotherapeutics for hematology, clinical immunology, and intensive care—sourcing raw material from its own plasma collection centers across Europe and processing them in company-owned manufacturing facilities. Operations span R&D, manufacturing, regulatory compliance, and direct sales across multiple countries. Core infrastructure is SAP-based (ECC, S/4HANA, HANA) for enterprise resource planning and business analytics, with Siemens industrial control systems managing production automation.
SAP (ECC, S/4HANA, HANA, Analytics Cloud, RISE), Siemens S7 and TIA Portal for process control, DB2, ABAP, Java, and Microsoft Office. Actively adopting SAP BTP.
Equipment qualification and validation, process control system design, automation system optimization, multi-year automation investment planning, new equipment commissioning, and GMP compliance process qualification.
Other companies in the same industry, closest in size